Horizon Pharma PLC

Deals

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
USD300.0008Nov-24Sr. UnsecuredB3B--FixedTsy--7158.75%-100.00000
Tranche Comments
8 yr: Redemption: 2019-11-01; Registration: 144A/Reg S; Comments: US$300m. Cpn 8.75%. Due 11/1/24 NC3. Ip par. Yld 8.75%. +715bp vs. 2.375% 8/15/24 UST. Settlement date 10/25/16. Cusip # 44053FAA8.;
Refinancing
Yes

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research